Statin therapy and related risk of new-onset type 2 diabetes mellitus-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Statin therapy and related risk of new-onset type 2 diabetes mellitus

Published:2014-06 Issue:5 Volume:25 Page:401-406
ISSN:0953-6205
Container-title:European Journal of Internal Medicine
language:en
Short-container-title:European Journal of Internal Medicine

Author:

Ruscica Massimiliano^ORCID,Macchi Chiara,Morlotti Beatrice,Sirtori Cesare R.,Magni Paolo

Publisher

Elsevier BV

Subject

Internal Medicine

Reference53 articles.

1. Statin therapy for primary prevention of cardiovascular disease;Taylor;JAMA,2013

2. Pharmacotherapy: statins and new-onset diabetes—the important questions;Preiss;Nat Rev Cardiol,2012

3. Modulation of insulin secretion from normal rat islets by inhibitors of the post-translational modifications of GTP-binding proteins;Metz;Biochem J,1993

4. A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia;Ohrvall;Metabolism,1995

5. Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials;Sattar;Lancet,2010

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The fermented milk can be a natural ally against obesity? Investigation of bovine milk fermentation by Lacticaseibacillus casei LBC 237, screening, and In silico predictions of bioactive peptides for obesity control;Intelligent Pharmacy;2024-08

2. Effect of berberine on pharmacokinetics and pharmacodynamics of atorvastatin in hyperlipidemia rats;Xenobiotica;2023-12-02

3. The sex-associated burden of atherosclerotic cardiovascular diseases: An update on prevention strategies;Mechanisms of Ageing and Development;2023-06

4. Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps: Nutraceuticals and hypercholesterolaemia;European Atherosclerosis Journal;2023-04-20

5. PCSK9 Inhibition and Risk of Diabetes: Should We Worry?;Current Atherosclerosis Reports;2022-11-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3